Enveric Biosciences To Sell Cannabinoid-Related Cancer Intellectual Property; Stock Up In Pre-Market

Biotechnology company, Enveric Biosciences, Inc. (ENVB), Friday announced that it has agreed to divest cancer-targeting cannabinoid-related intellectual property for an undisclosed amount.

Related Keywords

China , Japan , Canada , Australia , , Nasdaq , Enveric Biosciences Inc , Enveric Biosciences , Cancer , Biotechnology , Intellectual Property , Cannabinoid , Europlastogen ,